Medroxyprogesterone acetate

Medroxyprogesterone Acetate can cause cancer according to The World Health Organization’s International Agency for Research on Cancer (IARC). It can cause developmental toxicity according to state or federal government labeling requirements. Medroxyprogesterone acetate is an acetate ester resulting from the formal condensation of the 17alpha-hydroxy group of medroxyprogesterone with the carboxy group of acetic acid. A widely used progestin in menopausal hormone therapy and in progestogen-only birth control. Among its listed roles, it functions as a progestin, an androgen, a female contraceptive drug, a synthetic oral contraceptive, an adjuvant, an inhibitor, an antioxidant and an antineoplastic agent. It is a steroid ester, an acetate ester, a 20-oxo steroid, a 3-oxo-Delta(4) steroid and a corticosteroid. Functionally, it is related to medroxyprogesterone. It is grouped under the following drug class(es): Oral Contraceptives, Progestins and Steroids. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Metigestrona, Gestapuran, Perlutex and Promone-E. Its PubChem CID is 6279.

CAS No 71-58-9
Molecular Formula C24H34O4
Molecular Weight 386.50 g/mol
Synonyms [(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate

Frequently Asked Questions